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Our paper (1) “Cell populations and cell
proliferation in the in vitro response of
normal mouse spleen to heterologous ery-
throcytes. Analysis by the hot pulse tech-
nique,” investigated the kinetics of antigen
driven proliferation of antibody forming
cells in culture and showed that different
populations of cells were involved in the
response to two different antigens, provid-
ing evidence for the clonal selection theory
proposed by both Sir McFarlane Burnet
and by David Talmage.
I was trained as a biochemist in Eng-
land but switched to immunology when I
was given the opportunity to come to the
United States to join John Vaughan’s lab
at the Medical College of Virginia in Rich-
mond, Virginia. I arrived in January 1957
and was soon immersed in the great debates
then raging in immunology.
At that time, the revolution in biol-
ogy was well underway. The double helix
model for DNA was propounded in 1953
but it took some time for the significance
of the double helix to sink in. The “central
dogma that DNA codes for RNA that codes
for protein” came later and the nature of
the genetic code and the mechanisms of
protein synthesis (messenger RNA, trans-
fer RNA, and ribosomes) were not com-
pletely worked out until 1964–66, more
than 10 years later.
Immunology, however, was a sepa-
rate arena. In 1957, most experiments in
immunology were carried out in whole
animals. Antigen in, wait 10 days, anti-
body out, and everything in between took
place in a black box. The structure of
the antibody molecule, immunoglobulin
genes, cytokines, signaling pathways, and
almost all of what we now study was all
unknown.
It was thought that the architecture of
the lymphoid organs was essential to their
proper function (and indeed, we are just
now coming back to that same under-
standing) and it worried people that half
the spleen cells put out into culture were
dead in 24 h. As a biochemist, accustomed
to the study of metabolism in cell free
fractions, I was not deterred and pushed
ahead regardless. Our first goal was to get
immune responses from single cell sus-
pensions in vitro where we could study
them and manipulate them under various
conditions.
At that time, there was no in vitro system
that did anything other than just demon-
strate that antibody was being made and
most employed tissue slices or fragments
rather than single cell suspensions (2). The
trick that led to our success was to start
the response in vivo and then switch to cul-
ture and continue the response in vitro. The
assay for antibody was the measurement
of incorporation of radiolabeled amino
acid into antibody that could be recovered
by coprecipitation with antigen antibody
complexes (2). Using this, we could quan-
titate the rate of antibody synthesis and
measure the kinetics of the response and
determine how it was affected by culture
conditions. Our first application was to
investigate the metabolic activity of anti-
body formation and to show that the incor-
poration radiolabeled phosphate into acid
soluble, fat soluble, RNA, and DNA phos-
phate was increased in antibody forming
cultures. From today’s perspective, this was
not the most obvious thing to do but
many investigators were conducting similar
analyses in the study of protein synthe-
sis. People looked on antibody synthesis in
lymphoid organs in the same way that they
looked on albumin synthesis in the liver.
The protein was assumed to be made in all
the cells of the organ, not as the product of
small but rapidly expanding subset of the
cells, and it seemed that the global analy-
sis of the accompanying biochemical events
might be revealing. This proved not to be
the case but our focus was soon switched
to more profitable studies.
We went that April, to the Sympo-
sium on“Antibodies: Their production and
mechanism of action” sponsored by the
Biology Division of the Oak Ridge National
Laboratory, Oak Ridge, Tennessee. Presen-
tations from the meeting were published
in the Journal of Cellular and Compar-
ative Physiology Volume 50, Supplement
1, December 1957 and contained papers
by Frank Dixon, Jon Singer, Elvin Kabat,
David Talmage, and N.A. (Av) Mitchi-
son, to mention just a few that may still
be known to the “elders” in our field.
Also, presented were two papers by “young
Turks,” one by Novelli and DeMoss (3)
and the other by Schweet and Owen (4),
both of which sought to apply the new
understanding of the molecular biology
of the control of protein synthesis to the
synthesis of antibody. They received only
a mixed reception from the old school
immunologists, brought up in a disci-
pline still isolated from the main body of
biology.
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After the meeting, we made our way by
car to the annual AAI/FASEB meeting that
year in Chicago but bumped into Talmage
and his family in the caverns at Mammoth
Caves in Kentucky, which led to an invita-
tion to visit him in his house while at the
meeting in Chicago. There, in the crowded
kitchen, Talmage, Burnet, Vaughan, and
others engaged in a vigorous argument of
the pros and cons of the, not yet quite crys-
tallized, clonal selection theory (5, 6), that
stated the individual antibody forming cells
were committed to the synthesis of just one
unique antibody. The theory allowed one
to explain many aspects of the induction
of immunological tolerance and generated
great excitement at the time.
In the years that followed, the clonal
selection theory became generally accepted,
based more on its intellectual appeal rather
than on experimental evidence, which was
actually somewhat conflicting.
Our contribution (1) in support of the
theory was to show that cells making one
antibody could be destroyed using a “hot
pulse” technique without affecting a sec-
ond population in the same culture that
were making another antibody.
The lead-up to this began years earlier
when we showed, in 1958, that an in vitro
antibody response could be drastically
reduced by 8-azaguaninne, an inhibitor of
RNA and DNA synthesis (7). Burnet had
suggested that the induction of antibody
synthesis might be analogous to the induc-
tion of inducible enzymes (8) and Creaser
had shown that inducible enzyme synthe-
sis in bacteria could be strongly inhibited
by 8-azaguaninne (9). We were worried,
however, that the 8-azaguaninne appeared
to be more generally toxic but our later
studies showed that antibody formation
was selectively inhibited by inhibitors of
DNA synthesis while the synthesis of other
proteins was less affected, suggesting that
antibody synthesis was somehow depen-
dent on DNA synthesis (10). We were able
to confirm that the antibody forming cells
were dividing (11) using an early version
of the hot pulse technique and, in 1962,
we showed that antigen actually stimu-
lated DNA synthesis as measured by the
increased uptake of tritiated thymidine in
cultures of lymphocytes from previously
immunized rabbits (12). It is, perhaps hard
to believe from our current perspective,
that this was a novel, exciting finding, but
the “obvious” is often not “obvious” until it
is “obvious.”
At that time, we did not know about
T-cells and B-cells and the role of T-cells
in the B-cell response, and we assumed
that the dividing cells were the antibody
forming cells. Now, we would presume that
T-cells are also a component and the assay
soon became a major assay in the hands
of Benacceraf, and others, for many T-cell
studies (13).
Later, in 1966, Mishell and I developed
a more sophisticated in vitro model (14) in
which we could generate a primary anti-
body response of mouse spleen cells to
various erythrocyte antigens and it was this
that we used to show that responses to dif-
ferent antigens were carried out by different
cells. By this time, we had adopted the use
of the hemolytic plaque assay (15), devel-
oped by Jerne and Nordin (16), and we
could measure the actual number of cells
making antibodies to erythrocyte antigens.
We started the response to antigen A, killed
the cells making the response by letting the
dividing cells incorporate highly radioac-
tive tritiated thymidine, diluted the triti-
ated thymidine with unlabeled thymidine,
and then started the response to antigen B.
The two antigens were sheep erythrocytes
and burro (donkey) erythrocytes, and the
results were the same whether we started
with burro or sheep. Other experiments in
the paper showed that the first round of
proliferation did not begin until 24 h after
the addition of antigen to naïve cells but
was earlier if the cells were from immu-
nized donors and that virtually all the anti-
body forming cells arose from the extensive
proliferation of a much smaller number of
precursor cells.
The idea for the hot pulse technique,
which we used here and in our earlier paper
(11), came from my undergraduate days
where I had learned of the studies of Her-
shey et al. (17) in which they showed that
phage infection of Escherichia coli could
be progressively destroyed if the DNA was
labeled with radioactive 32P. In their tech-
nique, it was the disintegration of the 32P
that destroyed the link between successive
nucleotide triphosphates of the DNA, while
in our technique (11),we showed that it was
the very soft beta irradiation of the incor-
porated tritium that killed only the cells
that had incorporated the hot thymidine as
they synthesized new DNA.
Subsequent studies with the same
in vitro system led to the identification of
a T-cell replacing factor (18), the effect
of mitogens on T-cell help (19), posi-
tive and negative allogeneic effects (20),
and the true nature of the relationship
between CD8 and CD4 T-cells and the
recognition of Class I and Class II MHC
(21, 22).
In my memory, I had seen us led inex-
orably to the truth by a series of searing
insights but as I reread the papers I see
that we only stumbled our way to a better
understanding.
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